Lilly CEO to Retire in Dec.; David Ricks Named as Successor
Source: BFW (Bloomberg First Word)
Tickers
LLY US (Eli Lilly & Co)
People
John Lechleiter (Eli Lilly & Co)
Topics
Who's News - People
Management Changes
To de-activate this alert, click here
UUID: 7947283
(Bloomberg) -- Lilly says John C. Lechleiter, chairman, president, CEO, will retire as president and CEO effective December 31; David A. Ricks, currently SVP and president, Lilly Bio-Medicines, to assume the role of president and CEO on January 1.
Alert: HALISTER- Ricks to become chairman on June 1
Source: BFW (Bloomberg First Word)
Tickers
LLY US (Eli Lilly & Co)
People
John Lechleiter (Eli Lilly & Co)
Topics
Who's News - People
Management Changes
To de-activate this alert, click here
UUID: 7947283